Skip to main content
logo
Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.535
+0.025 (1.66%)
At close: Aug 14, 2026, 4:00 PM EDT
1.610
+0.075 (4.89%)
After-hours: Aug 14, 2026, 7:53 PM EDT

Enveric Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6443429
Market Cap Growth
106.00%1.92%20.78%-30.19%-85.19%-99.98%
Enterprise Value
1-01-1-168
Last Close Price
1.533.6364.51234.00374.408370.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.570.892.291.540.281.31
P/TBV Ratio
1.120.892.351.730.302.12

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----0.000.01
Net Debt / Equity Ratio
-0.97-1.12-1.41-1.17-1.13-0.77
Net Debt / EBITDA Ratio
0.610.550.240.140.900.70
Net Debt / FCF Ratio
0.610.570.290.161.001.48
Quick Ratio
10.665.091.501.074.438.33
Current Ratio
11.675.381.841.534.618.51
Return on Equity (ROE)
-183.12%-304.04%-539.57%-197.47%-97.57%-380.82%
Return on Assets (ROA)
-96.72%-134.11%-163.09%-86.20%-53.92%-102.60%
Return on Capital Employed (ROCE)
-162.40%-210.00%-604.70%-840.80%-128.30%-102.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-204.89%-236.13%-262.70%-573.02%-427.33%-167.81%
FCF Yield
-141.67%-219.16%-211.97%-467.23%-410.21%-39.91%
Buyback Yield / Dilution
-814.40%-698.70%-249.38%---
SEC Filings: 10-K · 10-Q